Board and Spokespersons
A member at the board of directors represents each partnering institution as well as the research fields of medical, bio-molecular, physiological, behavioral and psychological neuroscience, with a maximum of 10 active board members in total.
The board of directors is responsible for coordinating research plans within the CBBS and advises the spokespersons on topics of strategic development and funding decisions.
|
 Prof. Dr. med. Emrah Düzel
Institute of Cognitive Neurology and Dementia Research,
Otto von Guericke University and Speaker of German Center for Neurodegenerative Diseases
(spokesman)
short-CV
|
|
|
 Prof. Dr. Tömme Noesselt
Institute for Psychology, Otto von Guericke University
(spokesman)
short-CV
|
|
Prof. Dr. Stefan Remy
Leibniz Institute for Neurobiology Magdeburg
(spokesman)
<span;">short-CV
|
|
Prof. Dr. Daniela Dieterich
Institute for Pharmacology and Toxicology,
Otto von Guericke University
short-CV
|
|
Prof. Dr. Ildiko Rita Dunay
Department of Inflammation and Neurodegeneration,
Otto von Guericke University
short-CV
|
|
Prof. Dr. med. Hans-Jochen Heinze
Medical Director of University Hospital,
Otto von Guericke University,
Department Behavioral Neurology,
Leibniz Institute for Neurobiology
short-CV
|
|
Dr. Janelle Pakan
CBBS Research Group Neural Circuits & Network Dynamics, Otto von Guericke University
short-CV
|
|
 Prof. Dr. Stefan Pollmann
Institute for Psychology, Otto von Guericke University
short-CV
|
|
 Prof. Dr. Oliver Stork
Institute for Biology, Otto von Guericke University
short-CV
|
|
 Prof. Dr. med. Markus Ullsperger
Institute for Psychology, Otto von Guericke University
short-CV
|
|
 apl. Prof. Dr. Constanze Seidenbecher
Scientific Administration,
Leibniz Institute for Neurobiology Magdeburg
(consultative member)
|
